SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-045473
Filing Date
2021-08-30
Accepted
2021-08-30 07:30:28
Documents
14
Period of Report
2021-08-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea146612-8k_180life.htm   iXBRL 8-K 32847
2 PRESS RELEASE DATED AUGUST 30, 2021 ea146612ex99-1_180life.htm EX-99.1 42299
  Complete submission text file 0001213900-21-045473.txt   311381

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20210830.xsd EX-101.SCH 3789
4 XBRL DEFINITION FILE atnf-20210830_def.xml EX-101.DEF 27748
5 XBRL LABEL FILE atnf-20210830_lab.xml EX-101.LAB 36804
6 XBRL PRESENTATION FILE atnf-20210830_pre.xml EX-101.PRE 26366
7 EXTRACTED XBRL INSTANCE DOCUMENT ea146612-8k_180life_htm.xml XML 5587
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211221009
SIC: 2834 Pharmaceutical Preparations